Bioorganic and Medicinal Chemistry Letters p. 2000 - 2007 (2006)
Update date:2022-08-02
Topics:
Li, Qun
Woods, Keith W.
Thomas, Sheela
Zhu, Gui-Dong
Packard, Garrick
Fisher, John
Li, Tongmei
Gong, Jianchun
Dinges, Jurgen
Song, Xiaohong
Abrams, Jason
Luo, Yan
Johnson, Eric F.
Shi, Yan
Liu, Xuesong
Klinghofer, Vered
Des Jong, Ron
Oltersdorf, Tilman
Stoll, Vincent S.
Jakob, Clarissa G.
Rosenberg, Saul H.
Giranda, Vincent L.
Structure-based design and synthesis of the 3,4′-bispyridinylethylene series led to the discovery of 3-isoquinolinylpyridine 13a as a potent PKB/Akt inhibitor with an IC50 of 1.3 nM against Akt1. Compound 13a shows excellent selectivity against distinct families of kinases such as tyrosine kinases and CAMK, and displays poor to marginal selectivity against closely related kinases in the AGC and CMGC families. Moreover, 13a demonstrates potent cellular activity comparable to staurosporine, with IC50 values of 0.42 and 0.59 μM against MiaPaCa-2 and the Akt1 overexpressing FL5.12-Akt1, respectively. Inhibition of phosphorylation of the Akt downstream target GSK3 was also observed in FL5.12-Akt1 cells with an EC50 of 1.5 μM. The X-ray structures of 12 and 13a in complex with PKA in the ATP-binding site were determined.
View MoreShanghai Sunway Pharmaceutical Technology Co.,Ltd.
Contact:+86-21-5161 3915
Address:Shanghai YangPu
zhuzhou zhongle chemical co. ltd.
Contact:+86-0731 28228409
Address:Zhuzhou, Hunan, China
Ningxia Soochow Agrochemical Limited Company
Contact:(+86)0512 6320 8190
Address:wujiang
Jinan Trio PharmaTech Co., Ltd
Contact:86-531-88811783;+(0)13153010282
Address:2766 Yingxiu Road, Jinan High-Tech Zone, China
Rugao Jinling Chemical Co., Ltd.(expird)
Contact:0086-513-68005586
Address:Lianluo new village huangshi town Rugao city Jiangsu Province.
Doi:10.1039/b208907f
(2003)Doi:10.1039/jr9500003159
(1950)Doi:10.1002/(sici)1099-0690(200005)2000:9<1815::aid-ejoc1815>3.0.co;2-8
(2000)Doi:10.1002/hlca.19750580208
(1975)Doi:10.1021/jm00238a019
(1975)Doi:10.1016/0039-128X(79)90114-4
(1979)